Skip to main content
MADRIGAL PHARMACEUTICALS, INC. logo

MADRIGAL PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · MDGL ISIN · US5588681057 LEI · 549300CHIMT2EUSNJB60 US Manufacturing
Filings indexed 1,022 across all filing types
Latest filing 2023-01-19 Director's Dealing
Country US United States of America
Listing US MDGL

About MADRIGAL PHARMACEUTICALS, INC.

https://www.madrigalpharma.com/

Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious and progressive liver disease with high unmet medical need. The company's research led to the first U.S. Food and Drug Administration (FDA)-approved treatment for MASH. Madrigal's therapeutic goal is to halt or reverse liver scarring (fibrosis) and resolve the disease before patients experience severe complications, including cirrhosis, liver failure, and the need for transplantation.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2023-01-19 English
FORM 4 SUBMISSION
Director's Dealing
2023-01-19 English
FORM 4 SUBMISSION
Director's Dealing
2023-01-19 English
FORM 4 SUBMISSION
Director's Dealing
2023-01-19 English
FORM 4 SUBMISSION
Director's Dealing
2023-01-19 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text includes clinical trial results updates and a forward-looking statement disclaimer, typical for a current report. It does not contain comprehensive financial statements or detailed management discussion typical of Annual Reports (10-K) or Interim Reports (IR). It is not a transcript, proxy, or governance document. The document is over 10,000 characters and contains substantive information about a clinical trial update, which fits the nature of a Regulatory Filing (RNS) as a general announcement that does not fit other specific categories. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-01-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.